Solving Formulation Challenges Across Modalities: Patient-Centric Nanoparticle Approaches for Small and Large Molecules

Explore how advanced nanoparticle engineering is transforming formulation across both small and large molecule modalities. Dr. Chris Worrall highlights how Nanoform’s technologies enable higher drug‑loading oral tablets, ultra‑high‑concentration biologic formulations for SubQ delivery, and new possibilities for pulmonary administration. Through real case studies, you’ll see how nanoforming can reduce pill burden, unlock patient‑friendly alternatives to IV infusion, and improve therapeutic performance across modalities.

Key learning objectives:
– Overview of Nanoform’s Innovative Small and Large Molecule Nanoforming Technology Platforms to enable patient centric dosage forms
– Case studies showcasing reduction in pill size and overall pill burden whilst maintaining exposure of supersaturating ASDs
– A review of alternative dosage forms to IV infusions for large molecule therapeutics